, therapeutic approaches that target both diseases are needed. Clinical
trials are currently underway to explore
Sangeet, Ghai,,
Ni, Tiffany T.,
Pavlovich, Christian P.,
Futterer, Jurgen J.,
Schade, George R.,
Sanchez-Salas, Rafael,
Cornud, Francois,
Eggener, Scott,
Feller, John F.,
George, Arvin K.,
Villers, Arnauld,
de la Rosette, Jean (2025) ), and histotripsy. Methods: A comprehensive literature search was conducted to identify studies and clinical
trials prospective
controlled trial was conducted with three groups of women: group 1 (n=13)- with precancerous
CONNORS, J.M.,
SAVAGE, K.J,
JURCZAK, W,
LECH-MARANDA, E.,
SMOLEWSKI, P,
WALEWSKI, J,
STRAUS, D.J.,
YOUNES, A.,
ANSELL, S.M.,
KIM, W.S.,
GALLAMINI, A.,
ALEKSEEV, S.,
ILLÉS, A.,
ROSTA, A.,
PICARDI, M.,
ZINZANI, P.L.,
OKI, Y.,
FELDMAN, T.,
BARTLETT, N.L.,
CHEN, R.,
RAMCHANDREN, R.,
CUNNINGHAM, D.,
RADFORD, J.,
JOSEPHSON, N.C.,
SONG, E.,
SACHS, J.,
JOLIN, H.A.,
HUEBNER, D.,
LIU, R.,
LIPATOV, O.N. (2018)
for relapsed and refractory Hodgkin’s lymphoma.
METHODS
We conducted an open-label, multicenter,
randomizedРОЛЬ КАРВЕДИЛОЛА В ПРЕДОТВРАЩЕНИИ АПОПТОЗА КАРДИОМИОЦИТОВ ПРИ ОСТРОМ ИНФАРКТЕ МИОКАРДАЗакирова, А.Н.,
Гарифуллин, Б.Н.,
Закирова, Н.Э.,
Zakirova, N.E.,
Garifullin, B.N.,
Zakirova, A.N. (2017) in calcium concentration in mitochondrial
matrix. The experimental results and the data of large
randomized